NFKB1 and inflammatory bowel disease: Lactobacillus spp., which belongs to Firmicutes at the phylum level, has been demonstrated to possess the capacity to both prevent and reduce the incidence of inflammatory bowel disease and other inflammatory diseases by modulating the JAK/STAT and NF-κB signaling pathways [25,27].